Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/138832
Title: Antituberculosis activity of the antimalaria cytochrome bcc oxidase inhibitor SCR0911
Authors: Chong, Sherilyn Shi Min
Manimekalai, Malathy Sony Subramanian
Sarathy, Jickky Palmae
Williams, Zoe C.
Harold, Liam K.
Cook, Gregory M.
Dick, Thomas
Pethe, Kevin
Bates, Roderick Wayland
Grüber, Gerhard
Keywords: Science::Biological sciences::Biochemistry
Science::Biological sciences::Microbiology
Issue Date: 2020
Source: Chong, S. S. M., Manimekalai, M. S. S., Sarathy, J. P., Williams, Z. C., Harold, L. K., Cook, G. M., . . . Grüber, G. (2020). Antituberculosis activity of the antimalaria cytochrome bcc oxidase inhibitor SCR0911. ACS Infectious Diseases, 6(4), 725-737. doi:10.1021/acsinfecdis.9b00408
Journal: ACS Infectious Diseases
Abstract: The ability to respire and generate adenosine triphosphate (ATP) is essential for the physiology, persistence, and pathogenicity of Mycobacterium tuberculosis, which causes tuberculosis. By employing a lead repurposing strategy, the malarial cytochrome bc1 inhibitor SCR0911 was tested against mycobacteria. Docking studies were carried out to reveal potential binding and to understand the binding interactions with the target, cytochrome bcc. Whole-cell-based and in vitro assays demonstrated the potency of SCR0911 by inhibiting cell growth and ATP synthesis in both the fast- and slow-growing M. smegmatis and M. bovis bacillus Calmette–Guérin, respectively. The variety of biochemical assays and the use of a cytochrome bcc deficient mutant strain validated the cytochrome bcc oxidase as the direct target of the drug. The data demonstrate the broad-spectrum activity of SCR0911 and open the door for structure–activity relationship studies to improve the potency of new mycobacteria specific SCR0911 analogues.
URI: https://hdl.handle.net/10356/138832
ISSN: 2373-8227
DOI: 10.1021/acsinfecdis.9b00408
Rights: This document is the Accepted Manuscript version of a Published Work that appeared in final form in ACS Infectious Diseases, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acsinfecdis.9b00408
Fulltext Permission: embargo_20210417
Fulltext Availability: With Fulltext
Appears in Collections:SBS Journal Articles

Files in This Item:
File Description SizeFormat 
Chong_et al_acsinfecdis_2020.pdf
  Until 2021-04-17
935.84 kBAdobe PDFUnder embargo until Apr 17, 2021

Page view(s)

38
checked on Oct 21, 2020

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.